BridgeMD
New treatment option for Enteral Nutrition
Official title Stepwise Enteral Nutritional Algorithm and Patient Outcomes in Pediatric Intensive Care Units
ClinicalTrials.gov ID: NCT07307027
What this study is testing
- What it's testing
- The aim of the study to evaluate the effectiveness and patient's outcome after implementing enteral nutrition algorithm designed to achieve optimal enteral nutrition delivery in the pediatric intensive care unit and to evaluate the effect of implementing this protocol on critically ill patient's individual's outcome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 16
You may be able to join if
- Critically ill infants and children admitted to the Pediatric Intensive Care Units.
- Age range from 1 month to 16 years (specifically males up to 14 years and females up to 16 years).
You likely can't join if
- Patients who are discharged or died within 24 hours of admission.
- Patients with acute pancreatitis.
- Patients with esophageal perforation.
- Patients with a known metabolic disorder.
- Patients requiring a ketogenic diet.
- Patients with Short Bowel Syndrome.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Abbasia, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Abbasia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.